Review
Accepted on 23 Feb 2026
Insights into ectodomain shedding as a novel target in natural killer cell-based immunotherapy for cancer
in Cancer Immunity and Immunotherapy
Review
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Correction
Accepted on 23 Feb 2026
in Environmental Informatics and Remote Sensing
Original Research
Accepted on 23 Feb 2026
in Life-Course Epidemiology and Social Inequalities in Health
Original Research
Accepted on 23 Feb 2026
in Addictive Disorders
Original Research
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Feb 2026
in Clinical Research in Auditory Implants and Hearing Aids
Case Report
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Feb 2026
in Public Health Policy
Original Research
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 23 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Brief Research Report
Accepted on 23 Feb 2026
in Exercise Physiology
Original Research
Accepted on 23 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 23 Feb 2026
in Precision Medicine
Original Research
Accepted on 23 Feb 2026
in Pharmaceutical analysis
Original Research
Accepted on 23 Feb 2026
in Cancer Immunity and Immunotherapy